PT3820529T - Solubilizado com curcumina e pelo menos o canabinoide thc como uma substância ativa adicional - Google Patents
Solubilizado com curcumina e pelo menos o canabinoide thc como uma substância ativa adicionalInfo
- Publication number
- PT3820529T PT3820529T PT197367352T PT19736735T PT3820529T PT 3820529 T PT3820529 T PT 3820529T PT 197367352 T PT197367352 T PT 197367352T PT 19736735 T PT19736735 T PT 19736735T PT 3820529 T PT3820529 T PT 3820529T
- Authority
- PT
- Portugal
- Prior art keywords
- curcuminin
- solubilisate
- active agent
- further active
- cannabinoid thc
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title 1
- 229930003827 cannabinoid Natural products 0.000 title 1
- 239000003557 cannabinoid Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2018/068731 WO2019011955A2 (de) | 2017-07-11 | 2018-07-11 | Solubilisat mit curcumin und optional zumindest einem weiteren wirkstoff |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3820529T true PT3820529T (pt) | 2023-10-26 |
Family
ID=67180795
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT197367352T PT3820529T (pt) | 2018-07-11 | 2019-07-10 | Solubilizado com curcumina e pelo menos o canabinoide thc como uma substância ativa adicional |
PT197364045T PT3820528T (pt) | 2018-07-11 | 2019-07-10 | Solubilizado com curcumina e pelo menos um canabinoide como substância ativa adicional |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT197364045T PT3820528T (pt) | 2018-07-11 | 2019-07-10 | Solubilizado com curcumina e pelo menos um canabinoide como substância ativa adicional |
Country Status (11)
Country | Link |
---|---|
EP (2) | EP3820529B1 (pt) |
JP (2) | JP7254898B2 (pt) |
KR (2) | KR20210032424A (pt) |
CN (2) | CN112533638A (pt) |
BR (2) | BR112020026362A2 (pt) |
CA (2) | CA3103354A1 (pt) |
FI (1) | FI3820529T3 (pt) |
HR (1) | HRP20231263T1 (pt) |
PL (1) | PL3820528T3 (pt) |
PT (2) | PT3820529T (pt) |
WO (2) | WO2020011855A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4275694A1 (de) | 2022-05-13 | 2023-11-15 | Solmic Biotech GmbH | Verwendung von solubilisaten in erzeugnissen zur topischen anwendung |
WO2023139105A1 (de) | 2022-01-20 | 2023-07-27 | Solmic Biotech GmbH | Topisch anwendbare zusammensetzung enthaltend solubilisate lipophiler wirkstoffe |
WO2023250211A2 (en) * | 2022-06-24 | 2023-12-28 | Veroscience Llc | Treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH695661A5 (de) * | 2001-03-06 | 2006-07-31 | Forsch Hiscia Ver Fuer Krebsfo | Pharmazeutische Zusammensetzung. |
US7279185B2 (en) * | 2001-10-26 | 2007-10-09 | Metaproteonics, Llc | Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
DE50302729D1 (de) * | 2002-12-18 | 2006-05-11 | Doehler Gmbh | Xanthohumol-haltiges Getränk |
JP2005179213A (ja) * | 2003-12-17 | 2005-07-07 | Kaneka Corp | 肝臓障害抑制作用組成物とその製造方法 |
US20070104741A1 (en) * | 2005-11-07 | 2007-05-10 | Murty Pharmaceuticals, Inc. | Delivery of tetrahydrocannabinol |
CN101686725A (zh) * | 2007-04-03 | 2010-03-31 | 刚迦·拉贾·高卡拉贾 | 消炎和抗氧化协同作用的膳食补充组合物 |
WO2012093524A1 (ja) * | 2011-01-06 | 2012-07-12 | 花王株式会社 | 水中油型乳化組成物 |
CN103861090B (zh) * | 2012-12-18 | 2017-06-13 | 美迪思生物科技(北京)有限公司 | 含蛋白或多肽的疏水溶液、其制备方法及用途 |
DE202012012130U1 (de) * | 2012-12-19 | 2014-03-21 | Aquanova Ag | Curcuminsolubilisat |
US10213391B2 (en) * | 2014-05-06 | 2019-02-26 | Mewa Singh | Pharmaceutical compositions comprising hemp and turmeric to treat pain and inflammation |
WO2016022936A1 (en) * | 2014-08-07 | 2016-02-11 | Murty Pharmaceuticals, Inc. | An improved oral gastrointestinal dosage form delivery system of cannabinoids and/or standardized marijuana extracts |
US20160081975A1 (en) * | 2014-09-18 | 2016-03-24 | Virun, Inc. | Soft gel compositions and pre-gel concentrates |
WO2017066474A1 (en) * | 2015-10-15 | 2017-04-20 | Preleve Therapeutics, Llc | Compositions and methods for pain relief |
JP6781974B2 (ja) * | 2016-03-31 | 2020-11-11 | 国立大学法人 宮崎大学 | アドレノメデュリン凍結乾燥製剤の製造方法 |
IL248149B (en) * | 2016-09-29 | 2020-03-31 | Garti Nissim | Formulations of dilutable cannabinoids and processes for their preparation |
-
2019
- 2019-07-10 BR BR112020026362-1A patent/BR112020026362A2/pt unknown
- 2019-07-10 CA CA3103354A patent/CA3103354A1/en active Pending
- 2019-07-10 CN CN201980046466.6A patent/CN112533638A/zh active Pending
- 2019-07-10 HR HRP20231263TT patent/HRP20231263T1/hr unknown
- 2019-07-10 FI FIEP19736735.2T patent/FI3820529T3/en active
- 2019-07-10 EP EP19736735.2A patent/EP3820529B1/de active Active
- 2019-07-10 PT PT197367352T patent/PT3820529T/pt unknown
- 2019-07-10 CA CA3102663A patent/CA3102663A1/en active Pending
- 2019-07-10 PT PT197364045T patent/PT3820528T/pt unknown
- 2019-07-10 JP JP2021500589A patent/JP7254898B2/ja active Active
- 2019-07-10 WO PCT/EP2019/068538 patent/WO2020011855A1/de active Application Filing
- 2019-07-10 KR KR1020217003932A patent/KR20210032424A/ko active IP Right Grant
- 2019-07-10 JP JP2021500617A patent/JP2021524488A/ja active Pending
- 2019-07-10 WO PCT/EP2019/068537 patent/WO2020011854A1/de active Application Filing
- 2019-07-10 PL PL19736404.5T patent/PL3820528T3/pl unknown
- 2019-07-10 KR KR1020217003931A patent/KR102659259B1/ko active IP Right Grant
- 2019-07-10 EP EP19736404.5A patent/EP3820528B1/de active Active
- 2019-07-10 BR BR112020026393-1A patent/BR112020026393A2/pt unknown
- 2019-07-10 CN CN201980046360.6A patent/CN112469444A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
FI3820529T3 (en) | 2023-09-29 |
BR112020026393A2 (pt) | 2021-03-23 |
HRP20231263T1 (hr) | 2024-02-02 |
CN112533638A (zh) | 2021-03-19 |
KR102659259B1 (ko) | 2024-04-23 |
BR112020026362A2 (pt) | 2021-03-30 |
EP3820528A1 (de) | 2021-05-19 |
WO2020011854A1 (de) | 2020-01-16 |
JP2021524488A (ja) | 2021-09-13 |
PT3820528T (pt) | 2023-10-26 |
KR20210032423A (ko) | 2021-03-24 |
PL3820528T3 (pl) | 2024-01-29 |
CA3102663A1 (en) | 2020-01-16 |
JP7254898B2 (ja) | 2023-04-10 |
EP3820529B1 (de) | 2023-08-23 |
CA3103354A1 (en) | 2020-01-16 |
JP2021524271A (ja) | 2021-09-13 |
KR20210032424A (ko) | 2021-03-24 |
CN112469444A (zh) | 2021-03-09 |
EP3820528B1 (de) | 2023-08-30 |
WO2020011855A1 (de) | 2020-01-16 |
EP3820529A1 (de) | 2021-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL278224A (en) | Preparations of cannabidiol and their uses | |
ZA201905054B (en) | Electrosurgical energy conveying structure and electrosurgical device incorporating the same | |
GB202002677D0 (en) | Beamed elastomeric laminate structure, fit, and textute | |
IL256455B (en) | Phenoxyhalogenphenylamidines and the use thereof as fungicides | |
RS64636B1 (sr) | Solubilizat sa kurkuminom i bar kanabinoidom thc-om kao daljim aktivnim sastojkom | |
EP3768592C0 (en) | STRUCTURE CONSTRUCTION FOR AIRCRAFT AND AIRCRAFT INCLUDING STRUCTURE CONSTRUCTION | |
PT3820529T (pt) | Solubilizado com curcumina e pelo menos o canabinoide thc como uma substância ativa adicional | |
IL278881A (en) | Cannabinoids and their use | |
IL267184A (en) | Phenylamidines and the use thereof as fungicides | |
IL287929A (en) | Cannabinoids and their uses | |
SG11201908281VA (en) | Phenalene-1-one-containing photosensitizer composition, phenalene-1-one compound and the use thereof | |
GB201909462D0 (en) | eMeas and MDT | |
GB2562080B (en) | A fungicidal composition and the use thereof | |
IL267258A (en) | Phenoxyphenylamidines and the use thereof as fungicides | |
IL288828A (en) | Binding factors - cd38 and their use | |
EP3701119B8 (en) | Well design and associated well structures | |
EP3703805A4 (en) | MAGNETICALLY ASSISTED ADMINISTRATION IN AND THROUGH THE SKIN | |
KR102219947B9 (ko) | 촉매 및 이를 포함하는 전극 | |
EP3634475A4 (en) | REDUCTION OF AGROBACTERIUM ENDOTOXIN TOXICITY | |
PL3358118T3 (pl) | Zespół progu i próg | |
IL287503A (en) | Thio-semicarbazide compounds and their use | |
GB201917427D0 (en) | The flylead | |
GB201916822D0 (en) | The degravitator | |
GB2562082B (en) | A fungicidal composition and the use thereof | |
GB201902087D0 (en) | Medicament and the use thereof |